Resident physician and associate researcher at the Pancreas Center of the First Affiliated Hospital of Nanjing Medical University. The main research interest focus is on the role of immune microenvironment and metabolic reprogramming in the initiation and progression of pancreatic cancer. The relevant research results were published as the first author (including co-first) in Cell Death and Differentiation 2025a/b, Apoptosis 2024, Cancer Letters 2023, International Journal of Surgery 2023, Redox Biology 2022, et al. At present, my research is supported by the National Natural Science Foundation of China (No.82403000), and I serve on the young editorial committee of Med Research and Cancer Drug Resistance. In addition, I regularly review papers for SCI journals, including Cell Discovery, International journal of Surgery, Apoptosis, iScience, et al. Others: WPF Travel Grant (2020), APA Young Investigator Travel Grant (2022).